Timothy J Triche, Age 491601 Mackinaw Rd SE, Grand Rapids, MI 49506

Timothy Triche Phones & Addresses

1601 Mackinaw Rd SE, Grand Rapids, MI 49506

East Grand Rapids, MI

Pasadena, CA

Mammoth Lakes, CA

Altadena, CA

Los Angeles, CA

Washington, DC

Bethesda, MD

San Francisco, CA

Show more

Social networks

Timothy J Triche

Linkedin

Work

Company: CHILDRENS HOSPITAL LOS ANGELES Address: 4650 W Sunset Blvd, Los Angeles, CA 90027 Phones: (323) 660-2450 (Phone) (323) 660-7128 (Fax)

Education

School / High School: Tulane University of Louisiana 1971

Languages

English

Awards

Healthgrades Honor Roll

Ranks

Certificate: Anatomic Pathology, 1975

Mentions for Timothy J Triche

Career records & work history

Medicine Doctors

Timothy Triche Photo 1

Dr. Timothy J Triche, Los Angeles CA - MD (Doctor of Medicine)

Specialties:
Anatomic Pathology
Address:
CHILDRENS HOSPITAL LOS ANGELES
4650 W Sunset Blvd, Los Angeles, CA 90027
(323) 660-2450 (Phone) (323) 660-7128 (Fax)
Certifications:
Anatomic Pathology, 1975
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Tulane University of Louisiana
Graduated: 1971
Medical School
Barnes-Jewish Hospital
Graduated: 1971
Timothy Triche Photo 2

Timothy Junius Triche, Los Angeles CA

Specialties:
Pathology
Anatomic Pathology
Pediatric Pathology
Work:
Children's Hospital of Los Angeles
4650 W Sunset Blvd, Los Angeles, CA 90027
Education:
Tulane University (1971)
Barnes Jewish Hospital *Pathology
National Cancer Institute, Bethesda, Maryland *

Timothy Triche resumes & CV records

Resumes

Timothy Triche Photo 13

Timothy Triche

Publications & IP owners

Us Patents

Methods And Compositions For The Targeted Delivery Of Therapeutics

US Patent:
2007020, Aug 30, 2007
Filed:
Mar 24, 2006
Appl. No.:
11/388400
Inventors:
Timothy Triche - Los Angeles CA, US
Siwen Hu - Pasadena CA, US
International Classification:
A61K 31/765
A61K 31/715
US Classification:
424078370, 514054000
Abstract:
Disclosed herein are compositions and methods for the targeted delivery of a therapeutic agent. In one aspect, the invention pertains to glycopolymer-based particles complexed with a nucleic acid-based therapeutic. Other aspects of the invention relate to methods for treating various conditions by administering the particle compositions of the invention. In some embodiments, a cyclodextrin-based particle is used to deliver siRNA against one or more oncogenes.

Synthetic Spike-In Controls For Cell-Free Medip Sequencing And Methods Of Using Same

US Patent:
2023002, Jan 26, 2023
Filed:
May 4, 2022
Appl. No.:
17/736570
Inventors:
- Toronto, CA
- Grand Rapids MI, US
Daniel DINIZ DE CARVALHO - Toronto, CA
Michael M. HOFFMAN - Toronto, CA
Timothy J. TRICHE - Grand Rapids MI, US
International Classification:
C12Q 1/6858
Abstract:
There is described herein, a method of capturing and analyzing cell-free methylated DNA in a sample. The method involves subjecting the sample to library preparation to permit subsequent sequencing of the cell-free methylated DNA. A predetermined amount of control synthetic DNA fragments are added to the sample. The control synthetic DNA fragments each have a known nucleic acid sequence that does not align to a target genome sequence, and at least some of the control synthetic DNA fragments are methylated. The sample is denatured, and cell-free methylated DNA and the control synthetic DNA fragments are captured using a binder selective for methylated polynucleotides. The captured DNA is amplified and sequenced.

NOTICE: You may not use PeopleBackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. PeopleBackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.